Trump, however, was unpredictable and not a typical Republican. In contrast, prior to the Trump era, most Republicans opposed government-imposed pricing restrictions. The major companies had long feared unified Democratic control of Congress and the White House because most elected Democrats favor strong government regulation of drug pricing. How this “savings” came about is instructive.ĭonald Trump’s surprising ascent to the presidency scrambled political calculations, including for the drug industry. The savings, totaling $194 billion, was instrumental to hitting the budgetary objectives required for each to pass. In each of these cases, the bills were credited by the Congressional Budget Office (CBO) with cutting federal health costs by tens of billions of dollars. In 2021, Congress also approved a bipartisan infrastructure spending bill. Over the summer, the president signed into law the most significant new gun acquisition restrictions in several decades, which passed with bipartisan support, and the Inflation Reduction Act, with provisions subsidizing health insurance and restricting drug prices. They unwittingly created a large and illusory funding pool that Congress tapped to ease the passage of three separate measures. Less noticed is the improbable role Trump administration officials and pharmaceutical companies played in facilitating this agenda. Reviews of President Biden’s twenty months in office have become noticeably more upbeat in the wake of congressional approval of several consequential bills.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |